| scholarly article | Q13442814 |
| review article | Q7318358 |
| P2093 | author name string | Panteleon AE | |
| Rebrin K | |||
| Steil GM | |||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | preproinsulin | Q7240673 |
| P304 | page(s) | 125-144 | |
| P577 | publication date | 2004-02-01 | |
| P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
| P1476 | title | Closed-loop insulin delivery-the path to physiological glucose control | |
| P478 | volume | 56 |
| Q37004370 | A Feedforward-Feedback Glucose Control Strategy for Type 1 Diabetes Mellitus. |
| Q38570284 | A Review of Emerging Technologies for the Management of Diabetes Mellitus |
| Q36838643 | A Run-to-Run Control Strategy to Adjust Basal Insulin Infusion Rates in Type 1 Diabetes |
| Q30419609 | A bio-inspired glucose controller based on pancreatic β-cell physiology |
| Q39902142 | A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator |
| Q30502561 | A local glucose-and oxygen concentration-based insulin secretion model for pancreatic islets |
| Q40401927 | A novel insulin delivery algorithm in rats with type 1 diabetes: the fading memory proportional-derivative method |
| Q36159163 | A physiology-based model describing heterogeneity in glucose metabolism: the core of the Eindhoven Diabetes Education Simulator (E-DES) |
| Q37154369 | A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy |
| Q42958342 | A robust sliding mode controller with internal model for closed-loop artificial pancreas |
| Q54600648 | A synthetic approach toward a self-regulated insulin delivery system. |
| Q35593951 | Acute response in vivo of a fiber-optic sensor for continuous glucose monitoring from canine studies on point accuracy |
| Q33759539 | Adipose stem cell-based regenerative medicine for reversal of diabetic hyperglycemia |
| Q30409801 | Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative control |
| Q40451335 | An implantable subcutaneous glucose sensor array in ketosis-prone rats: closed loop glycemic control. |
| Q56351163 | Artificial Pancreas: Clinical Study in Latin America Without Premeal Insulin Boluses |
| Q36666262 | Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. |
| Q37538736 | Artificial pancreas: an emerging approach to treat Type 1 diabetes |
| Q30424200 | Artificial pancreas: past, present, future |
| Q46883136 | Blood glucose level neural model for type 1 diabetes mellitus patients |
| Q37834905 | Can technological solutions for diabetes replace islet cell function? |
| Q41458753 | Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas |
| Q36720439 | Clinical evaluation of a personalized artificial pancreas |
| Q46625409 | Clinical experience with an implanted closed-loop insulin delivery system |
| Q36720273 | Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial |
| Q36316740 | Closed-loop insulin delivery - what lies between where we are and where we are going? |
| Q27008127 | Closed-loop insulin delivery for treatment of type 1 diabetes |
| Q35954124 | Closed-loop insulin delivery in type 1 diabetes |
| Q33556720 | Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas |
| Q30424297 | Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery |
| Q37846089 | Closed-loop insulin delivery: from bench to clinical practice |
| Q43170486 | Closed-loop insulin delivery: is the Holy Grail near? |
| Q36367034 | Continuous glucose monitoring and closed-loop systems |
| Q36666292 | Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop |
| Q38104667 | Continuous glucose monitoring: 40 years, what we've learned and what's next |
| Q34245943 | Design and in silico evaluation of an intraperitoneal-subcutaneous (IP-SC) artificial pancreas |
| Q37404167 | Development of a clinical type 1 diabetes metabolic system model and in silico simulation tool |
| Q51171138 | Development of a highly responsive needle-type glucose sensor using polyimide for a wearable artificial endocrine pancreas. |
| Q30434551 | Diabetes: Models, Signals, and Control |
| Q37321586 | Effectiveness of Intravenous Infusion Algorithms for Glucose Control in Diabetic Patients Using Different Simulation Models |
| Q37331265 | Effectiveness of early intensive therapy on β-cell preservation in type 1 diabetes |
| Q38195730 | Emerging micro- and nanotechnology based synthetic approaches for insulin delivery |
| Q47773641 | Enhancing automatic closed-loop glucose control in type 1 diabetes with an adaptive meal bolus calculator - in silico evaluation under intra-day variability |
| Q30252197 | Future of Automated Insulin Delivery Systems |
| Q42557469 | Glucagon-like peptide-1 functionalized PEG hydrogels promote survival and function of encapsulated pancreatic beta-cells |
| Q40119161 | Glucose monitoring in acute care: technologies on the horizon |
| Q41842643 | Glucose-sensing pulmonary delivery of human insulin to the systemic circulation of rats |
| Q37404470 | Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes |
| Q42176960 | In silico evaluation of a control system and algorithm for automated insulin infusion in the ICU setting |
| Q37404176 | In silico simulation of long-term type 1 diabetes glycemic control treatment outcomes |
| Q37776812 | Induced L2-norm minimization of glucose–insulin system for Type I diabetic patients |
| Q47721261 | Insulin delivery and nocturnal glucose control in children and adolescents with type 1 diabetes |
| Q41978190 | Insulin delivery route for the artificial pancreas: subcutaneous, intraperitoneal, or intravenous? Pros and cons |
| Q33740862 | Is an automatic pump suspension feature safe for children with type 1 diabetes? An exploratory analysis with a closed-loop system |
| Q34054232 | Lessons from models of pancreatic beta cells for engineering glucose-sensing cells |
| Q51936487 | Long-range negative correlation of glucose dynamics in humans and its breakdown in diabetes mellitus. |
| Q33804654 | MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes |
| Q51092351 | Metabolic modelling and the closed-loop insulin delivery problem. |
| Q64290706 | Microneedle - Future prospect for efficient drug delivery in diabetes management |
| Q37404298 | Microneedle-based automated therapy for diabetes mellitus |
| Q37206883 | Microneedles Integrated with Pancreatic Cells and Synthetic Glucose-Signal Amplifiers for Smart Insulin Delivery |
| Q30414570 | Model-based sensor-augmented pump therapy |
| Q46892330 | On-line adaptive algorithm with glucose prediction capacity for subcutaneous closed loop control of glucose: evaluation under fasting conditions in patients with Type 1 diabetes. |
| Q38218567 | Pancreatic islet transplantation: from dogs to humans and back again |
| Q37776811 | Physiologic insulin delivery with insulin feedback: A control systems perspective |
| Q36242733 | Proportional Insulin Infusion in Closed-Loop Control of Blood Glucose |
| Q37628557 | Recent progress in mechanical artificial pancreas |
| Q37404293 | Statistical approach of assessing the reliability of glucose sensors: the GLYCENSIT procedure |
| Q34079626 | Stimuli sensitive polymers and self regulated drug delivery systems: a very partial review |
| Q46931044 | Sub-cutaneous closed-loop: continuous glucose measurement and external insulin pump: hope in treatment of type 1 diabetes |
| Q37787998 | Systems approaches and algorithms for discovery of combinatorial therapies |
| Q90684725 | The Bio-inspired Artificial Pancreas for Type 1 Diabetes Control in the Home: System Architecture and Preliminary Results |
| Q26852992 | The artificial pancreas: is it important to understand how the β cell controls blood glucose? |
| Q34894471 | The effect of insulin feedback on closed loop glucose control |
| Q36813552 | The effects of inpatient hybrid closed-loop therapy initiated within 1 week of type 1 diabetes diagnosis |
| Q34605978 | The future of open- and closed-loop insulin delivery systems |
| Q37159792 | The impact of parameter identification methods on drug therapy control in an intensive care unit |
| Q38131064 | The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas |
| Q37308148 | Treatment of diabetes mellitus using an external insulin pump: the state of the art. |
| Q30416614 | Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller |
| Q38044675 | Wearable and implantable pancreas substitutes |
| Q30431605 | Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events |
Search more.